By Kelly Cloonan
Odyssey Therapeutics has withdrawn the initial public offering it filed for in January.
The Boston-based biopharmaceutical company on Monday asked the Securities and Exchange Commission to retract the filing, which did not disclose an expected share price or the number of shares it planned to sell.
Odyssey said it had determined that it was not in its best interests to of the company to conduct an offering at this time.
The company had planned to list shares on the Nasdaq under the ticker ODTX.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
June 09, 2025 17:16 ET (21:16 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。